NCT00790725

Brief Summary

In this study, we want to compare two different kinds of artificial ventilation to see if one encourages faster weaning from breathing support and if one provides better sleep quality. These artificial ventilation types are:

  1. 1.Pressure support ventilation; the standard ventilation that we use for the patients in the Respiratory Acute Care Unit. Pressure support ventilation ventilators use constant air pressure to assist patients with their breathing.
  2. 2.Proportional assist ventilation; a newer way of helping people with their breathing. The air pressure provided by proportional assist ventilation ventilators varies with the size of the breath that a person takes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2008

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 13, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
Last Updated

April 25, 2012

Status Verified

April 1, 2012

Enrollment Period

1.5 years

First QC Date

November 11, 2008

Last Update Submit

April 24, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of time mechanically ventilated in the RACU

    30 days

Secondary Outcomes (6)

  • Sleep quality

    48 hours

  • Inflammatory mediator levels

    30 days

  • Hospital mortality

    30 days

  • 60 day mortality

    60 days

  • 180 day mortality

    180 days

  • +1 more secondary outcomes

Study Arms (2)

PAV

OTHER

Proportional Assist Ventilation will be used as a mechanical ventilation method for randomized patients in RACU

Other: Proportional Assist Ventilation

PS

OTHER

Pressure Support Ventilation will be used as a mechanical ventilation method for randomized patients in RACU

Other: Pressure Support Ventilation

Interventions

Proportional Assist Ventilation will be used to ventilate the patients.

PAV

Pressure Support ventilation will be used to ventilate the patients.

PS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Tracheotomized or endotracheally intubated and mechanically ventilated patients transferred or scheduled to be transferred to the RACU.
  • Age 18 years or older.

You may not qualify if:

  • High spinal cord injury
  • Immunosuppressed patients receiving chemotherapy or radiation therapy (\< 2 months after chemotherapy or radiation therapy).
  • Neuromuscular/ neurological disease of a progressive nature resulting in chronic ventilator dependence.
  • High risk of mortality within 3 months (severe neurological damage and cancer patients in terminal stages of the disease).
  • Patients unable to trigger the ventilator for any reason.
  • Any patient who is not considered a candidate for weaning from ventilatory support
  • Patients consented for another interventional study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Respiratory Aspiration

Interventions

Interactive Ventilatory Support

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Robert M Kacmarek, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia, Director of Respiratory Care Services

Study Record Dates

First Submitted

November 11, 2008

First Posted

November 13, 2008

Study Start

November 1, 2008

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

April 25, 2012

Record last verified: 2012-04

Locations